期刊文献+

分化型甲状腺癌组织中雌激素受体和孕激素受体表达的临床意义 被引量:8

Clinical Significance of the Expression of Estrogen Receptor and Progesterone Receptor in Differentiated Thyroid Carcinoma(with a 52-case report)
暂未订购
导出
摘要 目的:探讨分化型甲状腺癌是否为女性激素依赖性肿瘤,分析ER、PR的表达与分化型甲状腺癌患者的肿瘤大小、组织学类型、有否淋巴结转移、性别、年龄等的关系。方法:应用免疫组织化学方法(SP法)检测分析正常甲状腺、甲状腺良性肿瘤和分化型甲状腺癌组织中ER、PR的表达。结果:分化型甲状腺癌中ER和PR阳性表达分别为19.3%(10/52)和30.8%(16/52),其表达比正常甲状腺与良性肿瘤组织多,有显著性差异(P<0.01)。分化型甲状腺癌的肿瘤直径>1 cm的ER、PR阳性率明显高于≤1 cm的病例,有显著性差异(P<0.01)。而ER和PR的表达与患者的性别、年龄、组织类型和淋巴结转移无关。结论:分化型甲状腺癌组织中ER和PR的表达较正常甲状腺、甲状腺良性肿瘤组织高,有显著差异性(P<0.01),且肿瘤直径>1 cm者的ER和PR表达高于肿瘤直径≤1 cm者,揭示分化型甲状腺癌可能是雌激素和孕激素依赖性肿瘤。 Objective: ATo investigate whether differentiated thyroid carcinoma (DTC) is a hormone-dependent neoplasm, and analyze the relationship between the expressions of ER/PR in DTC with tumor size, histology types, lymph node metastasis, and gender, age. Methods: To detect the expression of estrogen receptor(ER)/Progesterone Receptors(PR) in normal thyroid tissue, thyroid benign tumor, and DTC by using the immunohistochemical staining technique (SP method). Results: There was no expression of ER/PR in most cases of normal thyroid tissue and benign tumor. The positive rates of ER/PR were 19.3% (10/52)/30.8% (16/52) in DTC. The positive rate of ER/ PR was significantly higher in DTC than in the normal thyroid tissue, nodular goiter, and follicular adenoma; there was a significant difference among them (P〈0.01). The positive rate of ER/PR in cases of tumor with diameter of more than 1 cm was significantly higher than those of tumor with diameter of not more than 1 cm; there was a significant difference between them (P〈0.01). However, the expression positive rate of ER/PR in DTC was related to gender, age, histology types, and lymph node metastasis. Conclusion: The positive rate of ERfPR in DTC was higher than those in normal thyroid tissue, nodular goiter, and follicular adenoma; there was a statistical significance among them (P〈0.01). The positive rate of ER/PR in cases of tumor with diameter of more than 1 cm was significantly higher than those of tumor with diameter of not more than 1 cm. The result suggested that DTC may be a kind of estrogen/progesterone-dependent neoplasm.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第24期2091-2093,共3页 Chinese Journal of Clinical Oncology
基金 2004年中山市科技局科研项目(编号:2004A075)资助~~
关键词 分化型甲状腺癌 雌激素受体 孕激素受体 免疫组织化学 Differentiated thyroid carcinoma Estrogen receptor Progesterone receptor Immunohistochemistry
  • 相关文献

参考文献11

二级参考文献45

  • 1张松平,倪灿荣,王能进.肝细胞癌及其周围肝组织中雌激素与孕激素受体的检测和分析[J].肿瘤研究与临床,1995,7(1):14-16. 被引量:1
  • 2王翠芳,李冠群,姜卫国.甲状腺癌性激素受体的临床病理分析[J].中华病理学杂志,1994,23(6):372-372. 被引量:6
  • 3李自强,谷化平,苏红,李春光,熊正文.甲状腺良、恶性病变中ER、PR、CEA和AgNOR相关性的研究[J].临床与实验病理学杂志,1995,11(2):129-129. 被引量:3
  • 4郑德先.细胞凋亡的研究进展[J].中华病理学杂志,1996,25(1):50-53. 被引量:47
  • 5Cvejic D,Savin S,Petrovic I,et al. Galectin-3 and proliferating cell nuclear antigen(PCNA) expressed in papillary thyroid carcinoma[ J ]. Exp Oneol, 2005,27( 3 ) : 210-214.
  • 6Augustynowicz A,Dzieciol J,Barwijuk-Machala M,et al. Assessment of proliferative activity of thyroid Hurthle cell tumors using PCNA, Ki-67 and AgNOR methods[J ]. Folia Histochemica et Cytobiologica,2004,42(3):165-169.
  • 7Lipponen P K,Ekelinen M J. Cell proliferation of transitional cell Bladder tumor's determined by PCNA/cyclin immunostraining and its prognostic value[J]. Br J cancer, 1992,66:171-179.
  • 8Leung D W,Cachianes G,Kuang W T,et al. Vascular endothelial growth factor is a secreted angiognic mitogen[J]. Science, 1989,246:1306-1307.
  • 9Tuttle R M,Fleisher M,Francis G L,et al. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short term TSH stimulation [J ]. Clin endocrinal Metab, 2002, 87(4) : 1737-1738.
  • 10Van Hoeven Kit,Menende Botet. Estrogen and progesterone receptor content was in human thyroid disease[J]. Am J Clin Pathol, 1993,99(2 ) : 175-185.

共引文献118

同被引文献136

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部